A preclinical study led by the Germans Trias i Pujol Research Institute (IGTP), in collaboration with the Institut de Myologie and the Sant Pau Research Institute, has analyzed the role of the protein HDAC11 in Duchenne muscular dystrophy (DMD) and its potential as a therapeutic target. The results of the study have recently been published in the journal Life Sciences.
This article was originally published on MedicalXpress.com

